These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 499287)

  • 1. Improved oral glucose tolerance following antiserotonin treatment in patients with chemical diabetes.
    Ferrari C; Barbieri C; Caldara R; Magnoni V; Testori GP; Romussi M
    Eur J Clin Pharmacol; 1979 Jul; 15(6):395-9. PubMed ID: 499287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of metergoline, a powerful and long-acting antiserotoninergic agent, on insulin secretion in normal subjects and in patients with chemical diabetes.
    Pontiroli AE; Viberti GC; Tognetti A; Pozza G
    Diabetologia; 1975 Apr; 11(2):165-7. PubMed ID: 1149950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired insulin secretion in human diabetes mellitus III. The effect of the serotonin antagonist metergoline.
    Giugliano D; Passariello N; Santoro L; Cerciello T; Gentile S
    Diabete Metab; 1981 Dec; 7(4):231-4. PubMed ID: 7037487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiserotonin treatment of hyperprolactinemic amenorrhea: long-term follow-up with metergoline, methysergide, and cyproheptadine.
    Crosignani PG; Peracchi M; Lombroso GC; Reschini E; Mattei A; Caccamo A; D'Alberton A
    Am J Obstet Gynecol; 1978 Oct; 132(3):307-12. PubMed ID: 707571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cyproheptadine administration on insulin secretion in acromegalic, diabetic and normal subjects.
    Feldman JM; Bivens CH; Skyler JS; Lebovitz HE
    Horm Metab Res; 1975 Jul; 7(4):279-83. PubMed ID: 1150128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.
    Kanat M; Norton L; Winnier D; Jenkinson C; DeFronzo RA; Abdul-Ghani MA
    Acta Diabetol; 2011 Sep; 48(3):209-17. PubMed ID: 21553243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance.
    Bock G; Dalla Man C; Campioni M; Chittilapilly E; Basu R; Toffolo G; Cobelli C; Rizza R
    Diabetes; 2006 Dec; 55(12):3536-49. PubMed ID: 17130502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state.
    Tripathy D; Carlsson AL; Lehto M; Isomaa B; Tuomi T; Groop L
    Diabetologia; 2000 Dec; 43(12):1476-83. PubMed ID: 11151756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin sensitivity and first-phase insulin secretion in obese Chinese with hyperglycemia in 30 and/or 60 min during glucose tolerance tests.
    Hong J; Zhang YF; Gu WQ; Zhang YW; Su YX; Chi ZN; Wang WQ; Li XY; Ning G
    Endocrine; 2008; 34(1-3):75-80. PubMed ID: 18979203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of nonglucose nutrients on insulin secretion and action in people with pre-diabetes.
    Bock G; Dalla Man C; Campioni M; Chittilapilly E; Basu R; Toffolo G; Cobelli C; Rizza R
    Diabetes; 2007 Apr; 56(4):1113-9. PubMed ID: 17395750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nateglinide improves early insulin secretion and controls postprandial glucose excursions in a prediabetic population.
    Saloranta C; Guitard C; Pecher E; De Pablos-Velasco P; Lahti K; Brunel P; Groop L
    Diabetes Care; 2002 Dec; 25(12):2141-6. PubMed ID: 12453951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance.
    Mitrakou A; Kelley D; Mokan M; Veneman T; Pangburn T; Reilly J; Gerich J
    N Engl J Med; 1992 Jan; 326(1):22-9. PubMed ID: 1727062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
    Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
    J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Insulin resistance and insulin secretion in type II non-obese diabetics].
    Pelikánová T; Válek J; Kazdová L; Saudek F; Karasová L
    Cas Lek Cesk; 1994 Mar; 133(6):172-6. PubMed ID: 8156572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin responses of children with chemical diabetes mellitus.
    Rosenbloom AL
    N Engl J Med; 1970 May; 282(22):1228-31. PubMed ID: 5442631
    [No Abstract]   [Full Text] [Related]  

  • 16. Prepregnancy weight and antepartum insulin secretion predict glucose tolerance five years after gestational diabetes mellitus.
    Metzger BE; Cho NH; Roston SM; Radvany R
    Diabetes Care; 1993 Dec; 16(12):1598-605. PubMed ID: 8299456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of moderate and high doses of human growth hormone on the insulin response to glucose infusion in prediabetic subjects.
    Luft R; Cerasi E; Werner S
    Horm Metab Res; 1969 May; 1(3):111-5. PubMed ID: 5407077
    [No Abstract]   [Full Text] [Related]  

  • 18. Kinetics of insulin secretion and glucose intolerance in adult patients with cystic fibrosis.
    Anzeneder L; Kircher F; Feghelm N; Fischer R; Seissler J
    Horm Metab Res; 2011 May; 43(5):355-60. PubMed ID: 21448848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study.
    Hanefeld M; Koehler C; Fuecker K; Henkel E; Schaper F; Temelkova-Kurktschiev T;
    Diabetes Care; 2003 Mar; 26(3):868-74. PubMed ID: 12610051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid, glucose, and insulin interrelationships in normal, prediabetic, and chemical diabetic subjects.
    Kyner JL; Levy RI; Soeldner JS; Gleason RE; Fredrickson DS
    J Lab Clin Med; 1976 Sep; 88(3):345-58. PubMed ID: 956689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.